Introducing New ACTICOATSNTM Flex


ACTICOAT◊ Flex

ACTICOAT◊ Flex has been designed to offer a highly conformable interface between the site of injury and secondary dressing. Protection is also provided through sustained antimicrobial performance.

  • Maintains contact with the wound bed even in awkward anatomical areas.
  • Kills pathogenic organisms common to wounds in order to reduce the risk of infection.1
  • Provides comfort for the patient during wear and allows them to move with the dressing still in place.6
  • May be used to complement negative pressure wound therapy protocols.3


Evidence

 

1. ACTICOAT◊ Flex is soft and highly flexible with stretch properties

 

  • Moves with the patient when they need to move the affected body part.6
  • Minimises discomfort for the patient.
  • Can be removed without causing trauma to the wound bed4.

 

 

2. ACTICOAT◊ Flex allows fluid transport into the secondary dressing to minimise the risk of maceration.5

 

Demand Absorbency

Absorbency (g)

 
Time (s)

 

  EXU-DRY◊   EXU-DRY◊ + ACTICOAT◊   EXU-DRY◊ + Silverlon™   EXU-DRY◊ + ACTICOAT◊ Flex 7 

 

 

3. ACTICOAT◊ Flex provides sustained (3 or 7 day) antimicrobial activity against a broad spectrum of wound pathogens including MRSA & Pseudomonas aeruginosa1

Removes the barrier to healing thus allowing the patient to regain control and progress the wound to healing.

Mean
log
reduction
(log10
cfu/
sample)		  

 

   0hr    4hr    24hr

 

Figure 1. Antimicrobial activity measured by log reduction of ACTICOAT◊ Flex 7 against common pathogenic wound pathogens over a 24 hour period (mean results, n=3)

 

4. ACTICOAT◊ Flex rapidly kills bacteria in as little as thirty minutes2.

Antibacterial action helps provide rapid protection from bacterial colonisation and aids in the prevention of resistance.

Mean
log
reduction
(log10
cfu/
sample)		  6.0  ACTICOAT Flex 3 graph
 5.0
 4.0
 3.0
 2.0
 1.0
 0.0
     Batch 081024-1 Batch 081026-2
ACTICOAT Flex 3		 Batch 081214-1

   S. aureus    P. aeruginosa

 

Figure 2. Antimicrobial activity measured by log reduction of ACTICOAT◊ Flex 3 against S. aureus and P. aeruginosa at 30 minutes (mean results, n=3)

 


Available with either 7 day or 3 day wear time

ACTICOAT◊ Flex is available with either 7 day (ACTICOAT◊ Flex 7) or 3 day (ACTICOAT◊ Flex 3) wear time.

There is a range of sizes to suit a range of indications.

Ordering codes

 

  • US
Catalogue# Size Carton quantity
ACTICOAT Flex 3  
66800402 2in x 2in 5
66800406 4in x 4in 12
66800417 4in x 8in 12
66800418 8in x 16in 6
66800433 16in x 16in 6 
66800434 4in x 48in 6
ACTICOAT Flex 7     
66800403  2in x 2in  5 
66800405  4in x 5in  5 
66800427  6in x 6in   5 
66800407  8in x 16in  6 
66800408  16in x 16in  6 

 

  • Rest of World

Catalogue# Size Carton quantity
ACTICOAT Flex 3  
66800396 5cm x 5cm 5
66800398 10cm x 10cm 5 
66800399 10cm x 10cm 12
66800409 10cm x 20cm 12
66800419 20cm x 40cm 6 
66800432 40cm x 40cm 6
66800435  10cm x 120cm  6 
ACTICOAT Flex 7     
66800395  5cm x 5cm  5 
66800397  10cm x 12.5cm  5 
66800420  15cm x 15cm   5 
66800400  20cm x 40cm  6 
66800401  40cm x 40cm  6 


References

1. Smith and Nephew Data on Files ref. 0812022. Antimicrobial activity of ACTICOAT◊ Flex 7 against pathogenic wound pathogens. (In-vitro data)

2. Smith and Nephew Data on Files ref. 0810018. ACTICOAT◊ Flex 3 has antimicrobial activity in 30 minutes. (In-vitro data)

3. Smith and Nephew Data on Files ref. 0810015. To show efficacy of ACTICOAT◊ Flex in combination with NPWT. (In-vitro data)

4. Smith and Nephew expert statement. ACTICOAT◊ wound bed preparation and wound trauma.

5. Smith and Nephew Data on File ref 0809009, Demand absorbency.

6. Smith and Nephew report ref. DS.08.123.R1